According to Goldstein Research, India pharmaceutical market size is anticipated to cross USD 76.7 billion by 2024, growing at a CAGR of 15.9% over the forecast period 2016-2024. More deals are expected to happen in Indian companies acquiring assets in US/Europe, rather than MNCs acquiring Indian companies. India Pharmaceutical Market segmentation has been done on the basis of type and geography. India has become the third largest global generic API merchant market by 2016, with a 7.2 percent market share and the India pharmaceutical industry accounts for the second largest number of Abbreviated New Drug Applications (ANDAs). India pharmaceutical market, by players, the highest expenditure based on research and development is done by Sun Pharma (USD 352 Million), followed by Dr. Reddy (USD 199 million). Further, Cipla formed an exclusive partnership with Serum Institute of India to sell vaccines in South Africa.Browse Full Report: https://www.goldsteinresearch.com/report/india-pharmaceutical-market-industry-overview

Market Segmentation

On the basis of our in-depth analysis, India Pharmaceutical Market can be segmented as follows:

• By Type
  
  
  
  Active Pharmaceutical Ingredients (APIs)
  
  Branded
  
  Generics
  
  Contract Research and Manufacturing Services
  
  Formulations (CRAMS)
  
  Chronic
  
  Cardiovascular
  
  Anti-Diabetes
  
  Gastro-Intestinal
  
  Neurological
  
  Acute
  
  Anti-infectives
  
  Respiratory
  
  Pain
  
  Gynecology
  
  Biosimilars

“India Pharmaceutical Market Outlook 2024” contains a detailed overview of the India pharmaceutical market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by type & geography.


Download Exclusive Sample Report:


https://www.goldsteinresearch.com/request-sample/india-pharmaceutical-market-industry-overview


Further, for the in-depth analysis, India Pharmaceutical Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Sun Pharma, Dr. Reddy, Lupin, Cipla, Aurobindo, Candela. Glenmark, Torrent Pharma, Alkem Lab, Divis Lab, Piramal Enter, Ipca Lab, Glaxo SmithKline, Abbott India, Biocon, Jubilant life, Sanofi India, Wockhardt, Pfizer, DrLal Path Lab, Merck, Hikal, Novartis India, Eris Life, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents the India pharmaceutical market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.


India Pharmaceutical Market is driving on the basis of advancement in mentioned below industries:


Nigeria Pharmaceutical Market


Regional government initiatives to curb the import and distribution of counterfeit medicines and significant investment by the government to develop a matured business environment are the major factors for the growth of Nigeria Pharmaceutical Market in the country. Nigeria pharmaceuticals market size is set to reach USD 5.3 billion by 2024, at a CAGR of 9.1% over the forecast years.


Global Biopharmaceutical and Biomedicine Market


Biopharmaceuticals & biomedicine deals with the research and development of drugs (biologics) partially or completely using biological compounds. The year 2017 has witnessed huge growth in the Biopharmaceutical Market. Biomedicines are increasingly penetrating the market as the drug manufacturers and other pharmaceutical companies are inclining towards R&D of biomedicine.


Global Pharmaceutical Herbal Extracts Market


Pharmaceuticals Herbal Extracts Market has immense growth prospects all over the world since ancient times, majorly in the Asia Pacific region. Herbal Extracts Market is mounting at a CAGR of 7.09% during the forecast period 2017-2025. Goldstein Research analyst forecast the pharmaceutical herbal extracts market size is set to reach nearly USD 10 billion by 2025, growing at a CAGR of 8.2% over the forecast period.


Singapore Pharmaceuticals Market


Singapore Pharmaceuticals Market anticipated to reach a market size of USD 530 billion, growing at a CAGR of 6.40% over the forecast period 2016-2024. Growth in adoption of modern healthcare technology and high demand for efficient healthcare system coupled with strong reimbursement policies is positively impacting the growth of Singapore pharmaceutical industry.